12006 Federal Register / Vol. 86, No. 38 / Monday, March 1, 2021 / Notices 

++ Determine the adequacy of 

ACHC’s staff and other resources. 

++ Confirm ACHC’s ability to provide 

adequate funding for performing 

required surveys. 

++ Confirm ACHC’s policies with 

respect to surveys being unannounced. 

++ Confirm ACHC’s policies and 

procedures to avoid conflicts of interest, 

including the appearance of conflicts of 

interest, involving individuals who 

conduct surveys or participate in 

accreditation decisions. 

++ Obtain ACHC’s agreement to 

provide CMS with a copy of the most 

current accreditation survey together 

with any other information related to 

the survey as we may require, including 

corrective action plans. 

In accordance with section 

1865(a)(3)(A) of the Act, the September 

28, 2020 proposed notice also solicited 

public comments regarding whether 

ACHC’s requirements met or exceeded 

the Medicare CoPs for HHAs. No 

comments were received in response to 

our proposed notice. 

IV. Provisions of the Final Notice 

A. Differences Between ACHC’s 

Standards and Requirements for 

Accreditation and Medicare Conditions 

and Survey Requirements 

We compared ACHC’s HHA 

accreditation requirements and survey 

process with the Medicare CoPs of parts 

409 and 484, and the survey and 

certification process requirements of 

parts 488 and 489. Our review and 

evaluation of ACHC’s HHA application, 

which were conducted as described in 

section III. of this final notice, yielded 

the following areas where, as of the date 

of this notice, ACHC has completed 

revising its standards and certification 

processes in order to meet the following 

requirements: 

• Section 484.102(b) to include the 

requirement to review and update 

emergency preparedness policies and 

procedures at least every 2 years. 

• Section 484.105(b)(1)(i) to ensure 

that the administrator is appointed by 

and reports to the governing body. 

• Section 488.26(b) to ensure 

surveyor documentation relating to noncompliance with particular Medicare 

conditions reflects the manner and 

degree of non-compliance, cited at the 

appropriate level (that is, condition 

versus standard level). 

• Section 488.5(a)(4)(vii) to describe 

ACHC’s procedures and timelines for 

monitoring provider’s or supplier’s 

correction of identified non-compliance 

with relevant standards, including the 

criteria ACHC uses to determine when 

a desk review versus an on-site review 

would be acceptable for monitoring the 

correction of non-compliance. 

B. Term of Approval 

Based on our review and observations 

described in section III. of this final 

notice, we approve ACHC as a national 

accreditation organization for HHAs that 

request participation in the Medicare 

program, effective February 24, 2021 

through February 24, 2025. 

V. Collection of Information 

Requirements 

This document does not impose 

information collection requirements, 

that is, reporting recordkeeping or thirdparty disclosure requirements. 

Consequently, there is no need for 

review by the Office of Management and 

Budget under the authority of the 

Paperwork Reduction Act of 1995 (44 

U.S.C. 3501 et seq.). 

The Acting Administrator of the 

Centers for Medicare & Medicaid 

Services (CMS), Elizabeth Richter, 

having reviewed and approved this 

document, authorizes Lynette Wilson, 

who is the Federal Register Liaison, to 

electronically sign this document for 

purposes of publication in the Federal 

Register. 

Dated: February 24, 2021. 

Lynette Wilson, 

Federal Register Liaison, Centers for Medicare 

& Medicaid Services. 

[FR Doc. 2021–04169 Filed 2–26–21; 8:45 am] 

BILLING CODE 4120–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Administration for Children and 

Families 

Submission for OMB Review; 

Comment Request; Healthy Marriage 

and Responsible Fatherhood 

Performance Measures and Additional 

Data Collection (New Collection) 

AGENCY: Office of Planning, Research, 

and Evaluation, Administration for 

Children and Families, HHS. 

ACTION: Request for public comment. 

SUMMARY: The Administration for 

Children and Families (ACF), Office of 

Family Assistance (OFA) has had 

administrative responsibility for federal 

funding of programs that strengthen 

families through healthy marriage and 

relationship education and responsible 

fatherhood programming since 2006, 

through the Healthy Marriage (HM) and 

Responsible Fatherhood (RF) Grant 

Programs. ACF required the 2015 cohort 

of HMRF grantees—which received 5- 

year grants in September 2015—to 

collect and report performance 

measures about program operations, 

services, and clients served (OMB 

#0970–0460). A performance measures 

data collection system called nFORM 

(Information, Family Outcomes, 

Reporting, and Management) was 

implemented with the 2015 cohort to 

improve the efficiency of data collection 

and reporting and the quality of data. 

This system allows for streamlined and 

standardized submission of grantee 

performance data through regular 

progress reports and supports granteeled and federal research projects. ACF 

will continue performance measure and 

other data collection activities for the 

HMRF grant program with a new cohort 

of grantees who received 5-year awards 

in September 2020. ACF is requesting 

comment on a new data collection to 

support these activities with the 2020 

HMRF grantee cohort. ACF has made 

changes to the previous cohort’s data 

collection instruments and performance 

reports for use in the new cohort. This 

new grantee cohort is expected to begin 

collecting performance measure data 

and reporting to ACF in April 2021. 

DATES: Comments due within 30 days of 

publication. OMB must make a decision 

about the collection of information 

between 30 and 60 days after 

publication of this document in the 

Federal Register. Therefore, a comment 

is best assured of having its full effect 

if OMB receives it within 30 days of 

publication. 

ADDRESSES: Written comments and 

recommendations for the proposed 

information collection should be sent 

within 30 days of publication of this 

notice to www.reginfo.gov/public/do/ 

PRAMain. Find this particular 

information collection by selecting 

‘‘Currently under 30-day Review—Open 

for Public Comments’’ or by using the 

search function. 

SUPPLEMENTARY INFORMATION: 

Description: ACF proposes to collect a 

set of performance measures from all 

HMRF grantees. These measures collect 

standardized information in the 

following areas: 

• Applicant characteristics; 

• Program operations; 

• Service delivery; and 

• Participant outcomes: 

Æ Entrance survey, with five versions: 

(1) HM Program Entrance Survey for 

Adult-Focused Programs; (2) HM 

Program Entrance Survey for YouthFocused Programs; (3) RF Program 

Entrance Survey for Community-Based 

Fathers; (4) RF Program Entrance Survey 

for Community-Based Mothers; and (5) 

Federal Register / Vol. 86, No. 38 / Monday, March 1, 2021 / Notices 12007 

RF Program Entrance Survey for 

Reentering Fathers. 

Æ Exit survey, with five versions: (1) 

HM Program Exit Survey for AdultFocused Programs; (2) HM Program Exit 

Survey for Youth-Focused Programs; (3) 

RF Program Exit Survey for CommunityBased Fathers; (4) RF Program Exit 

Survey for Community-Based Mothers; 

and (5) RF Program Exit Survey for 

Reentering Fathers. 

The measures used by the 2015 

grantee cohort were developed in 2014 

after extensive review of the research 

literature and grantees’ past measures. 

The performance measures, data 

collection instruments, and data 

collection system were revised in 2020 

based on a targeted analysis of existing 

measures, feedback from key 

stakeholders, and discussions with ACF 

staff and the 2015 cohort of grantees. 

ACF required the 2015 cohort of 

grantees to submit data on these 

standardized measures on a quarterly 

basis and proposes the same 

requirement for the 2020 cohort. In 

addition to the performance measures 

mentioned above, ACF proposes to 

repeat collection for these data 

submissions: 

• Semi-annual Performance Progress 

Report (PPR), with two versions: (1) 

Performance Progress Report for HM 

Programs, and (2) Performance Progress 

Report for RF Programs; and 

• Quarterly Performance Report 

(QPR), with two versions: (1) Quarterly 

Performance Progress Report for HM 

Programs, and (2) Quarterly 

Performance Progress Report for RF 

Programs. 

Grantees in the new cohort will also 

be required to engage in continuous 

quality improvement (CQI) planning 

and implementation using a proposed 

CQI plan template developed by ACF. 

The estimated burden for completing 

and updating this template is included 

in the table below. 

Respondents: Respondents include 

HM and RF grantee staff and program 

applicants and participants (participants 

are called ‘‘clients’’). 

ANNUAL BURDEN ESTIMATES

Instrument Respondent 

Number of 

respondents 

(total over 

request 

period) 

Number of 

responses per 

respondent 

(total over 

request 

period) 

Average 

burden per 

response 

(in hours) 

Total 

burden 

(in hours) 

Annual 

burden 

(in hours) 

1: Applicant Characteristics ................. Program applicants ............................. 273,840 1 0.25 68,460.0 22,820.0 

Program staff ...................................... 408 672 0.10 27,417.6 9,139.2 

2: Program Operations ........................ Program staff ...................................... 136 12 0.32 522.24 174.08 

3: Service Delivery Data ...................... Program staff ...................................... 2,040 126 0.50 128,520.0 42,840.0 

4: Entrance and Exit Surveys .............. Program clients (entrance) ................. 257,409 1 0.42 108,111.78 36,037.26 

Program clients (exit) .......................... 169,965 1 0.42 71,385.3 23,795.1 

Program staff (entrance and exit on 

paper).

32 3,506 0.10 11,219.2 3,739.73 

5: Semi-annual Performance Progress 

Report (PPR).

Program staff ...................................... 136 6 3 2,448.0 816.0 

6: Quarterly Performance Report 

(QPR).

Program staff ...................................... 136 6 1 816.0 272.0 

7: CQI Plan .......................................... Program staff ...................................... 136 3 4 1,632 544.0 

Estimated Total Annual Burden 

Hours: 140,177.37. 

Authority: Sec. 403. [42 U.S.C. 603]. 

Mary B. Jones, 

ACF/OPRE Certifying Officer. 

[FR Doc. 2021–04162 Filed 2–26–21; 8:45 am] 

BILLING CODE 4184–73–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Government-Owned Inventions; 

Availability for Licensing 

AGENCY: National Institutes of Health, 

HHS. 

ACTION: Notice. 

SUMMARY: The inventions listed below 

are owned by an agency of the U.S. 

Government and are available for 

licensing to achieve expeditious 

commercialization of results of 

federally-funded research and 

development. 

FOR FURTHER INFORMATION CONTACT: 

Licensing information and copies of 

patent applications may be obtained by 

emailing Brian W. Bailey, Ph.D., 

bbailey@mail.nih.gov, the indicated 

licensing contact at the National Heart, 

Lung, and Blood, Office of Technology 

Transfer and Development Office of 

Technology Transfer, 31 Center Drive, 

Room 4A29, MSC2479, Bethesda, MD 

20892–2479; telephone: 301–402–5579. 

A signed Confidential Disclosure 

Agreement may be required to receive 

any unpublished information. 

SUPPLEMENTARY INFORMATION: 

Technology description follows. 

Use of Statins To Treat or Prevent DrugInduced Hearing Loss 

Description of Technology 

Available for licensing and 

commercial development are patent 

rights covering methods of using 

atorvastatin and related statin 

compounds and derivatives to reduce or 

prevent drug-induced hearing loss that 

is caused as a side effect by ototoxic 

drugs such as cisplatin, which is 

commonly used in cancer therapies. At 

present, permanent hearing loss occurs 

in approximately half of all patients 

treated with cisplatin; consequently, 

every year many thousands of 

individuals experience partial loss of 

hearing and associated quality of life 

issues as a result of medically necessary 

chemoradiation therapies to treat their 

cancers. This technology addresses a 

large unmet need to eliminate or reduce 

hearing loss in patients that must 

undergo therapies involving ototoxic 

drugs. 

This technology is available for 

licensing for commercial development 

in accordance with 35 U.S.C. 209 and 37 

CFR part 404. 

Potential Commercial Applications 

• Repurposing existing statins, 

including atorvastatin, to treat or protect 

against permanent hearing loss arising 

from chemoradiation therapy involving 

ototoxic drugs. 

• Development of statin analogues or 

derivatives with enhanced abilities to 

treat or protect against hearing loss 

resulting from therapies involving 

cisplatin or other ototoxic drugs.